Detalles de la búsqueda
1.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer
; 26(6): 1020-1029, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610558
2.
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
Cancer Sci
; 112(4): 1567-1578, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548159
3.
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 467-476, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33136231
4.
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Br J Cancer
; 123(10): 1490-1495, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32863385
5.
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.
Gastric Cancer
; 23(1): 160-167, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309387
6.
[Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor:a case report].
Nihon Shokakibyo Gakkai Zasshi
; 117(7): 635-645, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-32655123
7.
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
Cancer Sci
; 110(9): 2875-2883, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254422
8.
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
Gastric Cancer
; 22(1): 138-146, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948386
9.
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
Cancer Sci
; 108(10): 2045-2051, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28763145
10.
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.
Gastric Cancer
; 20(4): 640-645, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27822684
11.
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
Oncology
; 91(1): 24-30, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27229742
12.
Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.
Pharm Res
; 33(2): 269-82, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26337772
13.
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Gastric Cancer
; 19(3): 919-26, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26474989
14.
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 477-478, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300101
15.
Doxorubicin- and Cyclophosphamide-Based Chemotherapy for Pregnant Women With Stage IIIa Breast Cancer.
Am J Ther
; 29(1): e120-e122, 2021 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491966
16.
Comparison of the effect of two types of whole mushroom (Agaricus bisporus) powders on intestinal fermentation in rats.
Biosci Biotechnol Biochem
; 80(10): 2001-6, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27309965
17.
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone.
Int J Clin Oncol
; 21(4): 668-675, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26733020
18.
[A Case of HER2-Positive Esophagogastric Junction Cancer with Perforation Curatively Resected after Neoadjuvant Chemotherapy plus Trastuzumab].
Gan To Kagaku Ryoho
; 43(6): 761-4, 2016 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-27306816
19.
Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
Invest New Drugs
; 33(1): 119-27, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242374
20.
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.
Invest New Drugs
; 33(5): 1068-77, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26163340